剂量放大决定了肺腺癌中的NKX2-1系因子对瘤的调节
John L Pulice1,2,3, Matthew Meyerson1,3,4,5
1Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
bioRxiv : the preprint server for biology
|November 23, 2023
概括
放大瘤基因驱动癌症,但剂量影响尚不清楚. 在肺腺癌中,由基因放大超过一个值而增加NKX2-1表达,驱动癌细胞生存和耐药性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 放大瘤基因表达是癌症的一个关键驱动因素.
- 通过放大基因剂量进行瘤调节的精确机制仍然不太清楚.
研究的目的:
- 调查基因放大在肺腺癌 (LUAD) 中的作用.
- 为了阐明NKX2-1转录因子的高剂量如何驱动LUAD.
- 为了确定NKX2-1剂量对治疗耐药性的影响.
主要方法:
- 在LUAD基因组中分析焦点放大.
- 通过NKX2-1.调查增强剂的可访问性和基因调节.
- 在LUAD细胞系中评估NKX2-1的依赖性和功能.
- 评估NKX2-1在EGFR抑制剂持久性中的作用.
主要成果:
- 最重要的LUAD放大针对NKX2-1.0.1附近的超级增强器.
- NKX2-1表达对LUAD细胞活力至关重要,并驱动一个血统上状态.
- 较高的NKX2-1剂量会对EGFR抑制剂产生抗性.
- 对于NKX2-1的瘤功能,需要一个临界剂量值.
结论:
- 基因拷贝数放大可以作为功能的变化.
- 超过值的高NKX2-1剂量对于LUAD瘤发生和治疗持续性至关重要.
- 了解剂量依赖性瘤基因调节对于癌症治疗至关重要.
更多相关视频
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
8.0K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.0K
相关概念视频
Dosage Compensation
6.2K
In animals, gender is determined by the number and type of sex chromosome. For example, human females have two X chromosomes, and males have one X and one Y chromosome, whereas C.elegans with one X chromosome is a male, and the one with two X chromosomes is a hermaphrodite.
In addition to sexual development, the X chromosome has genes involved in autosomal functions such as brain development and the immune system. Therefore, males and females with distinct numbers of X chromosomes will...
In addition to sexual development, the X chromosome has genes involved in autosomal functions such as brain development and the immune system. Therefore, males and females with distinct numbers of X chromosomes will...
6.2K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
